n(g)-iminoethylornithine has been researched along with Apoplexy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carmichael, ST; Doroudchi, MM; Gleichman, AJ; Hinman, JD; Llorente, IL; Ng, KL; Nunez, S; Sozmen, EG | 1 |
| Ay, H; Dalkara, T; Kirazli, S; Kocaefe, C; Moskowitz, MA; Ozcebe, O; Ozgüç, M; Qui, J; Topalkara, K; Yemisci, M | 1 |
1 trial(s) available for n(g)-iminoethylornithine and Apoplexy
| Article | Year |
|---|---|
Statin potentiates human platelet eNOS activity without enhancing eNOS mRNA and protein levels.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Bleeding Time; Blood Platelets; Brain Ischemia; Enzyme Inhibitors; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase Type III; Ornithine; Platelet Aggregation; Pravastatin; RNA, Messenger; Stroke; Treatment Outcome | 2008 |
1 other study(ies) available for n(g)-iminoethylornithine and Apoplexy
| Article | Year |
|---|---|
A Versatile Murine Model of Subcortical White Matter Stroke for the Study of Axonal Degeneration and White Matter Neurobiology.
Topics: Animals; Axons; Disease Models, Animal; Enzyme Inhibitors; Male; Mice; Mice, Inbred C57BL; Nerve Degeneration; Nitric Oxide Synthase Type III; Ornithine; Stroke; White Matter | 2016 |